Welcome to our dedicated page for Liveworld news (Ticker: LVWD), a resource for investors and traders seeking the latest updates and insights on Liveworld stock.
LiveWorld, Inc. (OTC Markets: LVWD) is a social-first digital agency and software company that regularly publishes detailed business and financial updates. The LVWD news feed features company-issued announcements that explain how LiveWorld combines social media engagement, compliance, and insight solutions with software and AI, with a particular focus on healthcare and pharmaceutical brands.
Investors and observers following LVWD news will find recurring quarterly and annual financial results, including condensed balance sheets, statements of operations, and cash flow statements. These releases highlight revenue trends, operating expenses, net income or loss, and cash and cash equivalents, providing insight into how LiveWorld’s social-first and AI-focused strategy aligns with its financial performance.
Beyond earnings, LiveWorld’s news includes updates on its AI initiatives, such as an AI strategic roadmap, increased investment in AI enablement across the agency, and the launch of AI-powered products. The company has announced AI Brand Reputation Indexes for pharmaceutical and over-the-counter consumer healthcare brands, describing how large language models and AI platforms shape brand perception.
Additional LVWD news items cover developments in healthcare and pharma marketing, new solution sets in areas like compliance support for digital and social media, and changes to the company’s board of directors that are tied to its AI and healthcare growth strategy. For anyone researching LiveWorld’s evolving role in social media–driven customer relationships, this news page offers a centralized view of the company’s financial disclosures, strategic direction, and AI-related projects.
LiveWorld, Inc. (OTC Markets: LVWD) reported second quarter 2021 revenues of approximately $2.5 million, an 18% increase from $2.1 million in Q2 2020. For the first half of 2021, revenues rose to approximately $4.7 million from $4.0 million year-over-year, with healthcare-related revenues growing 26%. The net income for Q2 2021 was about $130,000, up from $28,000 in Q2 2020, while the six-month net income reached $251,000 compared to a net loss of $61,000 in the previous year. As of June 30, 2021, the company held approximately $3.3 million in cash and equivalents, up from $2.6 million at 2020's end.
LiveWorld, Inc. (OTC Markets: LVWD) has launched a new dedicated Healthcare Professional (HCP) Social Media practice aimed at enhancing engagement with healthcare providers. This initiative, led by VP Strategy Danny Flamberg and Medical Director Umar Siddiqui, MD, responds to the increasing use of social media among physicians. According to QuantiaMD, 80% of surveyed physicians utilize social media for their practice. LiveWorld's expertise positions it to help pharmaceutical brands effectively communicate and promote their innovations through strategic social media engagement.
LiveWorld, Inc. (OTC Markets: LVWD) has announced its financial results for Q1 2021, reporting total revenues of approximately $2.2 million, up 17% from $1.9 million in Q1 2020. Healthcare-related revenues rose by 24% during this period. The company achieved a net income of approximately $121,000, compared to a net loss of $89,000 in the previous year, signaling improved profitability. Cash from operations also increased to $1.2 million, reflecting a 157% boost. Despite a reduction in cash and equivalents due to higher accounts receivable, the company remains focused on expanding digital services and maintaining profitability.
LiveWorld, Inc. (OTC Markets: LVWD) announced the appointment of Dr. Umar Siddiqui as Medical Director, reporting to Chairman & CEO Peter Friedman. This strategic addition underscores the company's commitment to enhancing digital and social media marketing expertise in biopharma, life sciences, and healthcare. Dr. Siddiqui brings over 15 years of experience in clinical research, health-system leadership, and digital health technology, having previously collaborated with PwC and Merck. His background is expected to strengthen LiveWorld's capabilities in providing innovative customer engagement solutions.